These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38558149)

  • 1. Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hua T; Fan H; Duan Y; Tian D; Chen Z; Xu X; Bai Y; Li Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Xu S; Jin Y; Li H; Zhuo Z; Zhang X; Liu Y
    J Neurol; 2024 Jun; 271(6):3595-3609. PubMed ID: 38558149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis.
    Cortese R; Battaglini M; Prados F; Gentile G; Luchetti L; Bianchi A; Haider L; Jacob A; Palace J; Messina S; Paul F; Marignier R; Durand-Dubief F; de Medeiros Rimkus C; Apostolos Pereira SL; Sato DK; Filippi M; Rocca MA; Cacciaguerra L; Rovira À; Sastre-Garriga J; Arrambide G; Liu Y; Duan Y; Gasperini C; Tortorella C; Ruggieri S; Amato MP; Ulivelli M; Groppa S; Grothe M; Llufriu S; Sepulveda M; Lukas C; Bellenberg B; Schneider R; Sowa P; Celius EG; Pröbstel AK; Granziera C; Yaldizli Ö; Müller J; Stankoff B; Bodini B; Barkhof F; Ciccarelli O; De Stefano N;
    Ann Neurol; 2024 Aug; 96(2):276-288. PubMed ID: 38780377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
    Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
    Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
    Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
    Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential patterns of spinal cord and brain atrophy in NMO and MS.
    Liu Y; Wang J; Daams M; Weiler F; Hahn HK; Duan Y; Huang J; Ren Z; Ye J; Dong H; Vrenken H; Wattjes MP; Shi FD; Li K; Barkhof F
    Neurology; 2015 Apr; 84(14):1465-72. PubMed ID: 25762714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
    Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
    Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 7 T MRI to assess atrophy of the subcortical deep gray matter in relapsing-remitting multiple sclerosis.
    Callen AM; Zurawski J; Chu R; Tie Y; Tauhid S; Quattrucci M; Healy BC; Bakshi R
    J Neurol; 2024 Oct; 271(10):6935-6943. PubMed ID: 39240345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
    Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
    Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
    Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
    Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enlarged choroid plexus in relapsing-remitting multiple sclerosis may lead to brain structural changes through the glymphatic impairment.
    Xie Y; Zhu H; Yao Y; Liu C; Wu S; Zhang Y; Zhu W
    Mult Scler Relat Disord; 2024 May; 85():105550. PubMed ID: 38493535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal magnetic resonance imaging quantification of gray matter alterations in relapsing-remitting multiple sclerosis and neuromyelitis optica spectrum disorder.
    Andica C; Hagiwara A; Yokoyama K; Kato S; Uchida W; Nishimura Y; Fujita S; Kamagata K; Hori M; Tomizawa Y; Hattori N; Aoki S
    J Neurosci Res; 2022 Jul; 100(7):1395-1412. PubMed ID: 35316545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cerebellar abnormalities in neuromyelitis optica--a comparison with multiple sclerosis and healthy controls.
    Weier K; Eshaghi A; Magon S; Andelova M; Radue EW; Kappos L; Azimi AR; Sahraian MA; Sprenger T
    Mult Scler; 2015 May; 21(6):757-66. PubMed ID: 25480863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
    Dong X; Xu G; Wang J; Yin N; Meng N
    Mult Scler Relat Disord; 2022 Sep; 65():103838. PubMed ID: 35749960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis.
    Pudlac A; Burgetova A; Dusek P; Nytrova P; Vaneckova M; Horakova D; Krasensky J; Lambert L
    Biomed Res Int; 2020; 2020():6492786. PubMed ID: 32509866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis.
    Cassiano MT; Lanzillo R; Alfano B; Costabile T; Comerci M; Prinster A; Moccia M; Megna R; Morra VB; Quarantelli M; Brunetti A
    Neuroimage Clin; 2020; 26():102201. PubMed ID: 32062567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders.
    Chien C; Brandt AU; Schmidt F; Bellmann-Strobl J; Ruprecht K; Paul F; Scheel M
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1362-1368. PubMed ID: 29748202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
    Chien C; Scheel M; Schmitz-Hübsch T; Borisow N; Ruprecht K; Bellmann-Strobl J; Paul F; Brandt AU
    Mult Scler; 2019 Dec; 25(14):1926-1936. PubMed ID: 30475082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.